The global cardiovascular health supplements market size is calculated at USD 12.96 billion in 2025 and is forecasted to reach around USD 25.83 billion by 2034, accelerating at a CAGR of 7.93% from 2025 to 2034. The Asia Pacific cardiovascular health supplements market size surpassed USD 5.05 billion in 2025 and is expanding at a CAGR of 8.06% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cardiovascular Health Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cardiovascular Health Supplements Market Revenue and Volume, by Type
8.1.1 Natural Supplements
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Synthetic Supplements
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Ingredient Outlook (Revenue, USD Million, 2018 - 2030)
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Vitamins & Minerals
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Herbs & Botanicals
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Omega Fatty Acids
8.1.6.1. Market Revenue and Volume Forecast
8.1.7. Coenzyme Q10 (CoQ10)
8.1.7.1. Market Revenue and Volume Forecast
8.1.8. Others
8.1.8.1. Market Revenue and Volume Forecast
9.1. Cardiovascular Health Supplements Market Revenue and Volume, by Form
9.1.1. Liquid
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Tablet
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Capsules
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Softgels
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Powder
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Others
9.1.6.1. Market Revenue and Volume Forecast
10.1. Cardiovascular Health Supplements Market Revenue and Volume, by Distribution Channel
10.1.1. Offline
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Online
10.1.2.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Type
11.1.2. Market Revenue and Volume Forecast, by Form
11.1.3. Market Revenue and Volume Forecast, by Distribution Channel
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Type
11.1.4.2. Market Revenue and Volume Forecast, by Form
11.1.4.3. Market Revenue and Volume Forecast, by Distribution Channel
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Type
11.1.5.2. Market Revenue and Volume Forecast, by Form
11.1.5.3. Market Revenue and Volume Forecast, by Distribution Channel
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type
11.2.2. Market Revenue and Volume Forecast, by Form
11.2.3. Market Revenue and Volume Forecast, by Distribution Channel
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Type
11.2.4.2. Market Revenue and Volume Forecast, by Form
11.2.4.3. Market Revenue and Volume Forecast, by Distribution Channel
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Type
11.2.5.2. Market Revenue and Volume Forecast, by Form
11.2.5.3. Market Revenue and Volume Forecast, by Distribution Channel
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Type
11.2.6.2. Market Revenue and Volume Forecast, by Form
11.2.6.3. Market Revenue and Volume Forecast, by Distribution Channel
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Type
11.2.7.2. Market Revenue and Volume Forecast, by Form
11.2.7.3. Market Revenue and Volume Forecast, by Distribution Channel
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Type
11.3.2. Market Revenue and Volume Forecast, by Form
11.3.3. Market Revenue and Volume Forecast, by Distribution Channel
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Type
11.3.4.2. Market Revenue and Volume Forecast, by Form
11.3.4.3. Market Revenue and Volume Forecast, by Distribution Channel
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Type
11.3.5.2. Market Revenue and Volume Forecast, by Form
11.3.5.3. Market Revenue and Volume Forecast, by Distribution Channel
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Type
11.3.6.2. Market Revenue and Volume Forecast, by Form
11.3.6.3. Market Revenue and Volume Forecast, by Distribution Channel
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Type
11.3.7.2. Market Revenue and Volume Forecast, by Form
11.3.7.3. Market Revenue and Volume Forecast, by Distribution Channel
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Type
11.4.2. Market Revenue and Volume Forecast, by Form
11.4.3. Market Revenue and Volume Forecast, by Distribution Channel
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Type
11.4.4.2. Market Revenue and Volume Forecast, by Form
11.4.4.3. Market Revenue and Volume Forecast, by Distribution Channel
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Type
11.4.5.2. Market Revenue and Volume Forecast, by Form
11.4.5.3. Market Revenue and Volume Forecast, by Distribution Channel
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Type
11.4.6.2. Market Revenue and Volume Forecast, by Form
11.4.6.3. Market Revenue and Volume Forecast, by Distribution Channel
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Type
11.4.7.2. Market Revenue and Volume Forecast, by Form
11.4.7.3. Market Revenue and Volume Forecast, by Distribution Channel
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Type
11.5.2. Market Revenue and Volume Forecast, by Form
11.5.3. Market Revenue and Volume Forecast, by Distribution Channel
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Type
11.5.4.2. Market Revenue and Volume Forecast, by Form
11.5.4.3. Market Revenue and Volume Forecast, by Distribution Channel
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Type
11.5.5.2. Market Revenue and Volume Forecast, by Form
11.5.5.3. Market Revenue and Volume Forecast, by Distribution Channel
12.1. NOW Health Group, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Bright Lifecare Pvt Ltd (Truebasics.com)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Natural Organics, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. DaVinci Laboratories of Vermont
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Nordic Naturals
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Thorne HealthTech, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Nestle (Pure Encapsulations, LLC.)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Amway
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. InVite Health
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. GNC Holdings, LLC
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample